Clinical Trial Detail

NCT ID NCT03751436
Title Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

prostate cancer

Therapies

Enzalutamide + Venetoclax

Age Groups: adult senior

No variant requirements are available.